Plain-English translation of NCT06584032 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a combination of two medications called and works better than standard chemotherapy for advanced endometrial cancer that has progressed after your first round of treatment. The study will randomly assign you to receive either this new medication combination or chemotherapy chosen by your doctor, and compare how well each one works and what side effects occur.
Many people with advanced endometrial cancer that returns or worsens after initial chemotherapy have limited treatment options. This trial exists to see whether this medication combination—which works in a different way than traditional chemotherapy—might offer better results for patients in this difficult situation.
You likely qualify if…
You likely don't qualify if…
If you qualify and are randomly selected, you would either receive the new medication combination or standard chemotherapy every three to four weeks. You would continue treatment until your doctor and the study team confirm that your cancer is progressing or until you experience unmanageable side effects. Throughout the trial, you would have regular doctor visits to check how well the treatment is working and monitor for side effects.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
China